HIKMA Pharmaceuticals PLC
ISIN: GB00B0LCW083 | Ticker: HIK | LEI: 213800HEZ5RG2KU77V41
Country: United Kingdom
Hikma Pharmaceuticals PLC is a global pharmaceutical company that is dedicated to providing high-quality, affordable medications to patients worldwide. With its headquarters in London, UK, and operations in the Middle East, Africa, Europe, and the United States, Hikma has established itself as a leader in the pharmaceutical industry.
The company has a diversified product portfolio that includes branded, generic, and injectable pharmaceuticals. Its focus is on developing and manufacturing innovative solutions for complex diseases, such as oncology, respiratory, and injectables.
1978
Served areaWorldwide
Headcount8,700
Headquarters1 New Burlington Place, W1S 2HR London – United Kingdom
| Position Holder | Short Interest in Percent | Date |
|---|---|---|
| Millennium International Management LP | 0.69% | 17.10.23 |
| Millennium International Management LP | 0.60% | 03.11.23 |
| Millennium International Management LP | 0.59% | 25.10.23 |
| Millennium International Management LP | 0.52% | 11.09.23 |
| Millennium International Management LP | 0.53% | 29.09.23 |
| Millennium International Management LP | 0.73% | 10.10.23 |
| Millennium International Management LP | 0.59% | 13.11.23 |
| Total | 4.25% |
GB00B0LCW083
LEI213800HEZ5RG2KU77V41
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryFTSE 250
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.